Cordant Health Solutions - About the company
Cordant Health Solutions is an acquired company based in Denver (United States), founded in 2012. It operates as a Company offering drug testing services for a wide range of applications including clinical trial testing. Cordant Health Solutions has raised $13.4M in funding. The company has 257 active competitors, including 41 funded and 28 that have exited. Its top competitors include companies like Roche, NVision Imaging Technologies and DiaSorin.
Company Details
Cordant Health Solutions is a premier drug testing laboratory for urine, blood, hair, and oral-fluids. In 2012, five labs AFTS labs, Forensic laboratories, Norchem laboratory, Secon laboratories, and Sterling Reference Labs came together under one vision: to simplify complex problems in the drug-testing industry and formed Cordant solutions. Services offered include medical monitoring, treatment drug testing, hospital services, health plans, controlled substance pharmacy, and workplace testing
- Website
- cordantsolutions.com
- Social
- Registered Address
- Tacoma, Washington
Key Metrics
Founded Year
2012
Location
Denver, United States
Stage
Acquired
Total Funding
$13.4M in 2 rounds
Latest Funding Round
Investors
Ranked
44th among 257 active competitors
Employee Count
11 as on Apr 30, 2026
Exit Details
Acquired by Waud Capital Partners (Apr 24, 2012)
Legal entities associated with Cordant Health Solutions
Cordant Health Solutions is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CORDANT HEALTH SOLUTIONS CIN: 364722458 , United States, Active | Dec 26, 999 | - | 669 (As on Dec 31, 2021) | - |
Cordant Health Solutions's acquisition details
Cordant Health Solutions got acquired by Waud Capital Partners on Apr 24, 2012.
Click here to take a look at Cordant Health Solutions's acquisition in detail
Sign up to download Cordant Health Solutions' company profile
Cordant Health Solutions's funding and investors
Cordant Health Solutions has raised a total funding of $13.4M over 2 rounds. Its first funding round was on Dec 29, 2014. Cordant Health Solutions has 1 institutional investor.
Here is the list of recent funding rounds of Cordant Health Solutions:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 16, 2015 | 4452831 | Series A | 8583665 | 4264162 | 6751471 | 3587638 |
Dec 29, 2014 | 7458718 | Seed | 6520721 | 6182808 | 9250930 | 3117288 |
Access funding benchmarks and valuations. Sign up today!View details of Cordant Health Solutions's funding rounds and investors
Cordant Health Solutions' founders and board of directors
Founder? Claim ProfileCordant Health Solutions' employee count trend
Cordant Health Solutions has 11 employees as of Apr 26. Here is Cordant Health Solutions's employee count trend over the years:
Uncover Cordant Health Solutions' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cordant Health Solutions's Competitors and alternates
Top competitors of Cordant Health Solutions include Roche, NVision Imaging Technologies and DiaSorin. Here is the list of Top 10 competitors of Cordant Health Solutions, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 | |
2nd |  NVision Imaging Technologies 2015, Ulm (Germany), Series A | Provider of medical imaging by quantum technologies | $35M | 61/100 | |
3rd | Develops and commercializes reagent kits for in vitro diagnostics | - | 56/100 | ||
4th |  Hangzhou Deshi Biotechnology 2016, Hangzhou (China), Public | Devices for HPV virus detection & RNA detection | $30.2M | 56/100 | |
5th | Developer of diagnostic tests using metabolomics and nuclear magnetic resonance spectroscopy | $26.8M | 55/100 | ||
6th | Developer of diagnostic instruments, reagents, and related software | - | - | 54/100 | |
7th |  EKF 1990, Penarth (United Kingdom), Public | Develops point-of-care and laboratory blood analyzers | $179K | 54/100 | |
8th | Atmo Biosciences 2017, Melbourne (Australia), Series B | Swallowable sensors for profiling intestinal gases | $7.01M | 53/100 | |
9th | SonoSite 1986, Bothell (United States), Acquired | Point-of-care ultrasound solutions provider, empowering clinicians with advanced imaging | - | 52/100 | |
10th | Company that provides clinical and molecular database of exceptional cancer survivors | $16.3M | 51/100 | ||
44th | Cordant Health Solutions 2012, Denver (United States), Acquired | Company offering drug testing services for a wide range of applications including clinical trial testing | $13.4M | 37/100 |
_1580727887253.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Cordant Health Solutions's competitors? Click here to see the top ones
Cordant Health Solutions's Investments and acquisitions
Cordant Health Solutions has made no investments or acquisitions yet.
News related to Cordant Health Solutions
Filter this list•
Apple Inc. (NASDAQ:AAPL) Shares Acquired by Silver Oak Advisory Group Inc.MarketBeat•Jan 30, 2025•Apple, SilverOakHealth, Bull & Oak, The Hershey Company and 3 others
•
•
•
•
•
Cordant Health Solutions Awarded Vendor Status With MMCAP InfuseNewswire•Mar 04, 2021•Cordant Health Solutions
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Cordant Health Solutions
Explore our recently published companies
- Commspartner - Unfunded company
- Sherpa Consulting - Woodside based, 2016 founded, Unfunded company
- Techlan - Unfunded company
